Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.42 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.42 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.42 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HRAS | P01112 | 1/20 | 0.40 |
| ▸ | FGF1 | P05230 | 1/20 | 0.39 |
| ▸ | FGF2 | P09038 | 1/20 | 0.39 |
| ▸ | VEGFA | P15692 | 1/20 | 0.39 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12604172 | 0.93 | SLC6A2 (0.41) | PTPN1SLC6A2LGALS9LGALS1LGALS3 | |
| SCHEMBL12604170 | 0.85 | MEN1 (0.42) | PTPN1SLC6A2MEN1KMT2A | |
| SCHEMBL12604193 | 0.84 | MEN1 (0.43) | SLC6A2LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL12798046 | 0.82 | MEN1 (0.40) | PTPN1SLC6A2LGALS9LGALS1LGALS3 | |
| SCHEMBL12650358 | 0.82 | MEN1 (0.40) | PTPN1SLC6A2LGALS9LGALS1LGALS3 | |
| SCHEMBL21852882 | 0.77 | MEN1 (0.65) | PTPN1SLC6A2L3MBTL1MEN1KMT2A | |
| SCHEMBL12798049 | 0.76 | SLC6A2 (0.37) | PTPN1SLC6A2LGALS9LGALS1LGALS3 | |
| SCHEMBL12650543 | 0.76 | SLC6A2 (0.37) | PTPN1SLC6A2LGALS9LGALS1LGALS3 | |
| SCHEMBL12604165 | 0.76 | L3MBTL1 (0.37) | L3MBTL1MEN1KMT2A | |
| SCHEMBL12604211 | 0.74 | KMT2A (0.45) | L3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987216-B2 | Polysulfated glycosides and salts thereof | Teva Hungary Pharmaceutical Marketing Private Limited Company (HU) | 2015-03-24 | — | — | US | disclosed |
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118198-A1 | POLYSULFATED GLYCOSIDES AND SALTS THEREOF | CFTR, AREG, STS | PTPN1 272/4885SLC6A2 2378/4885LGALS9 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.